The feasibility phase II trial for multidisciplinary therapy for borderline resectable pancreatic cancer.
Phase 1
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000025416
- Lead Sponsor
- Japanese foundation for cancer research, Cancer institute hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Distant metastasis 2)Unresectable local invasion 3)Previous chemotherapy performed within 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method